Skip to content
Preprint

LSEAD: A Privacy-Preserving LLM-Based Speech Analysis Framework for Early Alzheimer's Disease Screening

Aug 2026 · 0 citations · 67 references
Engineering Computer Science

TL;DR

Experimental results demonstrate that LSEAD provides a practical, secure, and scalable approach for early AD screening, and shows that LLM-based embeddings generalize well across datasets and improve AD classification accuracy by up to 5 percent over existing methods.

Abstract

Early diagnosis of Alzheimer's disease (AD) is critical for enabling timely interventions that may slow disease progression and improve patient outcomes. There is a growing need for AD detection methods that are non-invasive and cost-effective, especially in real-world clinical settings with diverse patient populations and recording conditions. Speech-based screening addresses these needs by using natural speech collected without specialized equipment. Recent advances in large language models (LLMs) have improved speech analysis by providing rich linguistic representations and strong generalization. In this study, we propose LSEAD, a speech-based AD detection framework using pretrained open-source LLMs. Speech recordings are automatically transcribed, and text embeddings are extracted using locally deployed LLMs. Principal component analysis (PCA) is applied to reduce dimensionality before classification. Because the framework relies only on speech transcripts and locally deployed models, it supports privacy-preserving AD risk assessment without external data exchange. We evaluate LSEAD on the ADReSS20 and ADReSSo2021 benchmark datasets. Experimental results show that LLM-based embeddings generalize well across datasets and improve AD classification accuracy by up to 5 percent over existing methods, especially for early-stage detection. These results demonstrate that LSEAD provides a practical, secure, and scalable approach for early AD screening.

View source

Similar papers

Jul 2026

Toward Generalizable Cognitive Impairment Detection with Speech-Based Multimodal Large Language Models

This work establishes a new state-of-the-art for CI identification, with the proposed method demonstrating superior cross-dataset generalization and the power of an LLM-based multimodal framework that fuses linguistic and acoustic data to enable robust, scalable, and non-invasive screening.

Ying-lei Huang, Xin Wang, Yuhan Su et al. · 0 citations
Jul 2026

Transcript-Free Lightweight Detection of Alzheimer's Disease from Spontaneous Speech Using Handcrafted MFCC-Dominant Acoustic Biomarkers

The results indicate that transcript-free spectro-temporal and fluency-related cues can facilitate speaker-independent Alzheimer's disease screening from raw audio, establishing a practical foundation for deployment-oriented research.

Rashin Gholijani Farahani, A. Bastanfard · 0 citations
Conference Jul 2026

A Foundational Framework for Voice-based Parkinsonian Biomarkers: Integrating Hybrid Deep Learning with Dual-Layer Explainability for Future Clinical Reference

Parkinson's Disease (PD) is a progressive neurodegenerative disorder, which also impacts speech and vocal characteristics at the initial stages of the disorder. This study proposes an explainable hybrid Bi-LSTM and XG-Boost for detection Parkinsons Disease using non-invasive voice recording, and is designed to be inter...

T. Bhutia, Passang Tamang, Dewash Manger et al. · 0 citations
Conference Jul 2026

A Systematic Review of Explainable NLP-based Handwriting Techniques for Early Prediction of Alzheimer’s Disease

Initial identification of Alzheimer’s disease (AD) a progressive neurological illness can greatly enhance patient care. Alternative approaches are necessary since traditional diagnostic techniques like neuroimaging are expensive, intrusive, and less accessible. This research work reviews the literature of existing stud...

A. S., K.Vidhya, A. Ebenezer · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.